Best Medical Instruments & Supplies Stocks for 2026

Diagnostics, lab-tool, and consumable makers run capital-light models with high, recurring gross margins; Quality dominates and Valuation weighs EV/EBITDA against growth.

Medical Instruments and Supplies covers diagnostics, lab tools, and the consumable bench. The cohort is capital-light with high gross margins and recurring revenue, so the Quality pillar (gross margin, ROIC, FCF conversion) dominates composite ranking; Valuation pillar uses EV/EBITDA against organic growth.

Data as of (updated daily)

Top 20 Medical Instruments & Supplies stocks by composite score

#TickerNameComposite
1300677.SHEShandong Intco Medical Products Co Ltd73.8
2301580.SHEAidite (Qinhuangdao) Technology Co., Ltd.69.6
36929.HKOrbusNeich Med Grp Hldg Ltd69.3
4688301.SHGiRay Technology Co Ltd69.3
5MARK.JKMark Dynamics Indonesia Tbk PT68.9
6AHC.AUAustco Healthcare Ltd68.7
7MRC.WARMercator Medical S.A.68.7
8301101.SHEMingyue Optical Lens Co.Ltd.67.5
9300453.SHEJiangxi Sanxin Medtec Co Ltd67.5
10OMED.JKJayamas Medica Industri65.8
111501.HKShanghai Kindly Medical Instruments64.8
12TSTL.LSETristel64.7
137153.KLSEKossan Rubber Industries Bhd63.4
14FIE.XETRAFielmann Aktiengesellschaft63.2
15688606.SHGHangzhou Alltest Biotech Co. Ltd. A63.1
169113.KLSEIconic Worldwide Bhd62.7
17603087.SHGGan & Lee Pharmaceuticals Co Ltd62.7
18688029.SHGMicro Tech Nanjing Co Ltd62.4
19RMD.USResMed Inc62.3
20RMD.AUResmed Inc61.4

Want to drill into Medical Instruments & Supplies stocks?

The full screener applies the Medical Instruments & Supplies industry filter and lets you stack 30+ more filters on top: market cap, country, dividend yield, and the four pillar scores.

Open in screener →

Methodology: How we score stocks. Data refreshed nightly around 03:30 ET. This page lists the top 20 by composite score; use the screener for the full ranked list.

Frequently asked questions about Medical Instruments & Supplies stocks

By using ShareValue.ai you agree to our Terms and Privacy Policy. Educational platform, not investment advice.